Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies (2017)
- Authors:
- USP affiliated authors: NAKAYA, HELDER TAKASHI IMOTO - FCF ; ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Subjects: MELANOMA; PELE
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 53, suppl. 1, p. 10 res. FCF016, 2017
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
OLIVEIRA, Erica Aparecida de et al. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 10 jan. 2026. , 2017 -
APA
Oliveira, E. A. de, Fernandes, D. K. A., Flores, F. F., Lima, D. S. de, Cardozo, L. E., Nakaya, H. T. I., & Maria-Engler, S. S. (2017). Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Oliveira EA de, Fernandes DKA, Flores FF, Lima DS de, Cardozo LE, Nakaya HTI, Maria-Engler SS. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 10 res. FCF016.[citado 2026 jan. 10 ] -
Vancouver
Oliveira EA de, Fernandes DKA, Flores FF, Lima DS de, Cardozo LE, Nakaya HTI, Maria-Engler SS. Targeting top1 gene in melanoma as a novel mechanism of resistance and combinational therapies. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 10 res. FCF016.[citado 2026 jan. 10 ] - Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1
- Integrative toxicogenomic and system biology platforms to target melanoma genes by DM-1
- Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of DM-1 compound toxicity in melanoma cells
- Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells
- Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood
- Systems biology of long non-coding RNAs in vaccination
- In situ immune signatures and microbial load at the nasopharyngeal interface in children with Acute Respiratory Infection
- Metabolic phenotypes of response to vaccination in humans
- Cancer immunology of cutaneous melanoma: a systems biology approach
- Fcoex: an R package for detecting co-expression modules in single-cell RNA-Seq data
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
